Ajinomoto Co Inc
TSE:2802
Ajinomoto Co Inc
Total Equity
Ajinomoto Co Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ajinomoto Co Inc
TSE:2802
|
Total Equity
¥811.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Yakult Honsha Co Ltd
TSE:2267
|
Total Equity
¥570.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Meiji Holdings Co Ltd
TSE:2269
|
Total Equity
¥742.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Kikkoman Corp
TSE:2801
|
Total Equity
¥493B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
Total Equity
¥479B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
Toyo Suisan Kaisha Ltd
TSE:2875
|
Total Equity
¥480.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
Ajinomoto Co Inc
Glance View
Ajinomoto Co., Inc., a household name synonymous with umami, has woven a rich tapestry in the fabric of the global food industry. Originally starting its journey in 1908, the company was founded by Dr. Kikunae Ikeda, who isolated and identified the flavor-enhancing properties of monosodium glutamate (MSG). It began its commercial journey by marketing this unique seasoning under the brand name "Ajinomoto," which translates to "essence of taste" in Japanese. Building upon this foundation, Ajinomoto has expanded far beyond MSG, leveraging its biochemical prowess to create a diverse range of food products and ingredients. This transition from a single product line to a multitude of culinary offerings has established Ajinomoto as a global leader in the food industry, catering to numerous markets with products that enhance the flavors of everyday meals. More than just a staple in pantries worldwide, Ajinomoto delves into the scientific realm of food and health. Its business model capitalizes not only on traditional seasoning products but also on innovative solutions in amino acids and wellness markets. The company generates revenue by harnessing biotechnologies to produce amino acids for pharmaceuticals, nutritional supplements, and the burgeoning wellness industry. Ajinomoto combines its biochemical expertise with a deep understanding of consumer trends to develop novel products that align with health and sustainability. Its strategic investments in technology and research empower the company to navigate contemporary challenges, ensuring its relevance and growth in an evolving marketplace. Through this dual focus on taste and health, Ajinomoto maintains its charismatic presence from bustling markets in Japan to homes across the globe.
See Also
What is Ajinomoto Co Inc's Total Equity?
Total Equity
811.4B
JPY
Based on the financial report for Dec 31, 2024, Ajinomoto Co Inc's Total Equity amounts to 811.4B JPY.
What is Ajinomoto Co Inc's Total Equity growth rate?
Total Equity CAGR 10Y
2%
Over the last year, the Total Equity growth was 1%. The average annual Total Equity growth rates for Ajinomoto Co Inc have been 8% over the past three years , 6% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet